Bristol Myers Shares New Data on COBENFY for Schizophrenia at Psych Congress, Highlighting Long-Term Safety and Patient Satisfaction
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024
Apple, Microsoft, Exxon, and More Stocks to Watch
Heard on the Street: Pfizer's Activist Battle Might Fizzle -- but Its Stock Probably Won't -- WSJ
Earnings Preview: BMY to Report Financial Results Pre-market on October 31
$Bristol-Myers Squibb(BMY.US)$ is scheduled to release its financial results pre-market on October 31 ET. Earnings PreviewAnalysts estimate $Bristol-Myers Squibb(BMY.US)$ to post revenue of USD11.25
Bristol-Myers Squibb Analyst Ratings